Wednesday, July 31, 2019 8:20:24 AM
Here is some background:
1. We announced back in June that we stop using a contract manufacturer, which we had used for VMS+2.0 and create an internal fabrication facility at our head office in Toronto.
2. This was possible as the VMS+3.0 is a much simpler and less-costly machine to fabricate due to the new tracking method which is a simple circuit board embedded in the adaptor for the ultrasound probe.
3. Of course we had to have the facility certified before we could begin to manufacture devices and this was achieved Thursday last week.
4. We have now fabricated the first two VMS+3.0 in this certified facility and will ship them tomorrow or Friday to fulfil the first two purchase orders, which were from a Heart Institute and a Children’s hospital in western Canada (their policies are not to allow third parties to name them in press releases).
5. This is major milestone for the company and its mission to improve cardiac care for children and adults.
6. It has been an amazing summer so far with Health Canada and European approvals for the VMS+3.0, the establishment of the new manufacturing centre and now first sales - all in under two months.
7. We have more orders coming soon from Canada and Europe will come back from vacation in September and again a number of sites have indicated they are ready to purchase the new system.
8. We are still awaiting US-FDA clearance and have been told the agency is working to complete their review as soon as possible. Again we have hospitals ready to acquire the VMS+3.0 as soon as it is approved in the USA.
9. Our Chinese partners are also advancing their sales pipeline and expect to have first sales very soon.
Recent VPTDF News
- Healthcare Stock Rallies Strongly Following Key Implementation • AllPennyStocks.com • 12/12/2023 06:30:00 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM